A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anthony El-Khoueiry, M.D.
USC Norris and HOAG sites
Principal Investigator - Anthony J. Olszanski, M.D., RPh
Fox Chase Cancer Center
Principal Investigator - Brian Schwartz, M.D.
Intensity Therapeutics
Study Director - Giles F Whalen, M.D.
UMASS Memorial Medical Group
Principal Investigator - Lillian Siu, M.D., FRCP
Princess Margaret Hospital, Canada
Study Chair - Luis Camacho, M.D.
Center for Oncology and Blood Disorders
Principal Investigator - Matthew Ingham, M.D.
Columbia University
Principal Investigator - Nilofer Azad, M.D.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Cancer Center - University Health Network
Toronto, Ontario, Canada
- Usc Norris
Los Angeles, California, United States
- Usc Hoag
Newport Beach, California, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- Umass Memorial Medical Center
Worcester, Massachusetts, United States
- Columbia University Medical Center
New York, New York, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Center for Oncology and Blood Disorders
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Feb 2017
- Primary completion
- 22 Feb 2023
- Completion
- 22 Feb 2023
- Last update posted
- 27 Feb 2025
- Registered enrollment
- 111
- Registry id
- NCT03058289
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.